Selective Inhibition of PI3K/Akt/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque
出版年份 2014 全文链接
标题
Selective Inhibition of PI3K/Akt/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 3, Pages e90563
出版商
Public Library of Science (PLoS)
发表日期
2014-03-06
DOI
10.1371/journal.pone.0090563
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis
- (2017) Somasundaram Subramaniam et al. Journal of the National Comprehensive Cancer Network
- Complement C2 siRNA mediated therapy of myasthenia gravis in mice
- (2013) Ruksana Huda et al. JOURNAL OF AUTOIMMUNITY
- Molecular Biology of Atherosclerosis
- (2013) Paul N. Hopkins PHYSIOLOGICAL REVIEWS
- MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins
- (2012) David Colecchia et al. Autophagy
- Autophagy Links Inflammasomes to Atherosclerotic Progression
- (2012) Babak Razani et al. Cell Metabolism
- Beclin 1 Is Required for Starvation-Enhanced, but Not Rapamycin-Enhanced, LC3-Associated Phagocytosis of Burkholderia pseudomallei in RAW 264.7 Cells
- (2012) Xuelei Li et al. INFECTION AND IMMUNITY
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- IKBKE Protein Activates Akt Independent of Phosphatidylinositol 3-Kinase/PDK1/mTORC2 and the Pleckstrin Homology Domain to Sustain Malignant Transformation
- (2011) Jian-Ping Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma
- (2011) Shoshana Greenberger et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
- (2010) Alberto M. Martelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane
- (2010) N Berndt et al. CELL DEATH AND DIFFERENTIATION
- IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway
- (2010) Hun-Jung Park et al. MOLECULAR IMMUNOLOGY
- Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
- (2009) Wen Qiang Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Heart Disease and Stroke Statistics—2009 Update
- (2009) et al. CIRCULATION
- Autophagy in Atherosclerosis
- (2009) Wim Martinet et al. CIRCULATION RESEARCH
- From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce TH1 development
- (2009) Anne O'Garra et al. NATURE IMMUNOLOGY
- The PI3K–PTEN tug-of-war, oxidative stress and retinal degeneration
- (2009) Kyung Hwa Kang et al. TRENDS IN MOLECULAR MEDICINE
- Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients
- (2008) B. L. Kasiske et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels
- (2008) Lin Zhong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor Necrosis Factor Blockers Influence Macrophage Responses toMycobacterium tuberculosis
- (2008) James Harris et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
- (2008) Tobias Sinnberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More